Stay updated on Belantamab Combo in Newly Diagnosed Myeloma Clinical Trial
Sign up to get notified when there's something new on the Belantamab Combo in Newly Diagnosed Myeloma Clinical Trial page.

Latest updates to the Belantamab Combo in Newly Diagnosed Myeloma Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedA minor update to the ClinicalTrials.gov page revision/version label is reflected (v3.5.2 → v3.5.3) without corresponding changes to the trial’s displayed record history content.SummaryDifference0.1%

- Check23 days agoChange DetectedThe history now shows a new Revision: v3.5.2 and removes the prior Revision: v3.5.0.SummaryDifference0.1%

- Check52 days agoChange DetectedSponsor information (Hellenic Society of Hematology), verification status, and last known status (Recruiting) were added for the 2023-11 update. The record history revision was updated from v3.4.3 to v3.5.0.SummaryDifference0.9%

- Check59 days agoChange DetectedA new revision, v3.4.3, has been added to the study record history and the previous revision v3.4.2 has been removed.SummaryDifference0.1%

- Check88 days agoChange DetectedA new revision entry (v3.4.2) was added to the study history. The funding-lapse notice and the previous revision entry (v3.4.1) were removed.SummaryDifference0.9%

- Check95 days agoChange DetectedNotice about government funding and open status was added, along with a new revision tag (v3.4.1), replacing the previous revision (v3.4.0).SummaryDifference0.9%

Stay in the know with updates to Belantamab Combo in Newly Diagnosed Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Belantamab Combo in Newly Diagnosed Myeloma Clinical Trial page.